Multiple Sclerosis: Disease and Treatment

Paper Summary:

This paper defines multiple sclerosis (MS) as a common neurological disorder responsible for substantial neurological morbidity. MS is an autoimmune disease that attacks the central nervous system, the spine and the brain. This paper evaluates and analyzes various published medical articles and research studies related to the treatment of MS. This paper discusses the use of interferon-beta-1a also known as Avonex, for the treatment of MS. The company that manufactures Avonex notes that while MS is an unpredictable disease in regards to symptoms, using Avonex as a once-a-week therapy can help slow the progression of disability in relapsing forms of MS. This paper contains case study results of patients with MS who used Avonex as well as other treatments and therapies.

Table of Contents:
What is Intramuscular Interferon Beta 1a Therapy?
Multiple Sclerosis and its Treatments
What is Avonex?
MS Footnotes
Bibliography

From the Paper:

"Despite the setback experienced by Avonex and patient's preference for Comaxone, treatment of multiple sclerosis has come a long way. Before the investigation into interferons, physicians were only able to treat some of their MS patients with Prednisone or other immunosuppressives. The problem with Prednisone or Methotrexate (a drug used to treat cancer and also used to repress rejection of transplanted organs) were first they were not that effective and second they had long term side effects which included osteoporosis and high cholesterol for Prednisone and the possibility of catching an infection and dying with Methotrexate."

More papers on Multiple Sclerosis: Disease and Treatment:

• Essay # 27578 : "Multiple Sclerosis"
• Essay # 32024 : "Multiple Sclerosis"
• Analytical Essay # 126850 : "Multiple Sclerosis and Canada"

APA Citation:

MLA Citation: